Abilify 10 mg tablets
Authorisation EU/1/04/276/006-010 · Otsuka Pharmaceutical Netherlands B.V.
- Licence holder
- Otsuka Pharmaceutical Netherlands B.V. (all products →)
- Active substance
- Aripiprazole
- Clinical trials
- 8 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC code
- N05AX12
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Aripiprazole: supply and approvals
55 authorised products on the HPRA list contain Aripiprazole. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 17 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 17 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 17 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 276. The HPRA list does not say whether it is on sale.
Other medicines with Aripiprazole in Ireland
52 other products on the HPRA list contain Aripiprazole, from 10 licence holders; 13 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Aripiprazole Clonmel 10 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Aripiprazole Clonmel 15 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Aripiprazole Clonmel 30 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Aripiprazole Clonmel 5 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Aripiprazole Krka 10mg Tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Aripiprazole Krka 15mg Tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Aripiprazole Krka 30mg Tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Aripiprazole Krka 5mg Tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Aripiprazole Pinewood 1 mg/ml Oral Solution | Pinewood Laboratories Limited | National authorisation (PA) | Marketed |
| Aripiprazole Teva 10 mg tablets | Teva B.V. | National authorisation (PA) | Marketed |
| Aripiprazole Teva 15 mg tablets | Teva B.V. | National authorisation (PA) | Marketed |
| Aripiprazole Teva 30 mg tablets | Teva B.V. | National authorisation (PA) | Marketed |
The licence holder
Otsuka Pharmaceutical Netherlands B.V. holds 30 products on the HPRA list, with 9 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.